Allakos Inc.
ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF
Last updated:
Abstract:
The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.
Status:
Application
Type:
Utility
Filling date:
17 May 2019
Issue date:
20 Feb 2020